parecoxib has been researched along with leukotriene e4 in 1 studies
| Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (leukotriene e4) | Trials (leukotriene e4) | Recent Studies (post-2010) (leukotriene e4) |
|---|---|---|---|---|---|
| 436 | 186 | 229 | 986 | 118 | 122 |
| Protein | Taxonomy | parecoxib (IC50) | leukotriene e4 (IC50) |
|---|---|---|---|
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | 9.83 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartra, J; Muñoz-Cano, R; Picado, C; Roca, J; Sánchez-López, J; Serrano, C; Valero, A | 1 |
1 trial(s) available for parecoxib and leukotriene e4
| Article | Year |
|---|---|
Safety of parecoxib in asthmatic patients with aspirin-exacerbated respiratory disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Cyclooxygenase 2 Inhibitors; Female; Forced Expiratory Volume; Humans; Isoxazoles; Leukotriene E4; Male; Middle Aged; Nasal Provocation Tests | 2011 |